Get the latest Science News and Discoveries
Experimental NIH malaria monoclonal antibody protective in Malian children - EurekAlert
One injected dose of an experimental malaria monoclonal antibody was 77% effective against malaria disease in children in Mali during the country’s six-month malaria season, according to the results of a mid-stage clinical trial. The trial assessed an investigational monoclonal antibody developed by scientists at the National Institutes of Health (NIH), and results appear in <em>The New England Journal of Medicine</em>.
None
Or read this on Eureka Alert